{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:45:05Z","timestamp":1794408305135,"version":"4.9.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T00:00:00Z","timestamp":1739664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T00:00:00Z","timestamp":1739664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Amolyt Pharma"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>In the CNHR study, 35% of postmenopausal women had osteoporosis by BMD or fragility fracture, and 4% had both. Three men\u2009\u2265\u200950 had osteoporosis by BMD or fragility fracture (33.3%; <jats:italic>n<\/jats:italic>\u2009=\u20093\/9). This suggests that close follow-up of skeletal health is necessary in postmenopausal women, and men\u2009\u2265\u200950 with chronic HypoPT.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Chronic hypoparathyroidism (HypoPT) has been associated with decreased bone turnover and abnormalities in bone mineral density (BMD), microarchitecture, and strength. Current guidelines do not recommend systematic evaluation of skeletal health in patients with chronic HypoPT. Our study assessed skeletal health in pre- and postmenopausal women with chronic HypoPT and adult men.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This prospective study enrolled adults with chronic HypoPT from the Canadian National Hypoparathyroidism Registry. Clinical characteristics, bone fractures, biochemistry, and serum bone biomarkers were assessed at baseline. Skeletal health evaluation included assessments of fragility fractures, BMD at lumbar spine (LS), femoral neck (FN), total hip (TH), 1\/3 radial sites, trabecular bone score (TBS), and bone biomarkers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We present the baseline data of the patients enrolled in the registry. We analyzed a total of 101 patients: 18 men, 35 premenopausal, and 48 postmenopausal women. The mean (SD) age at the onset of HypoPT was 40.7 (16.8) years, and the average disease duration was 11.2 (8.6) years. The\u00a0most common etiology was postsurgical (74.3% vs. 25.7% non-surgical). Most patients received calcium supplements (89%) and active vitamin D (80%) at baseline. No fragility fractures or low BMD were reported in premenopausal women. However, BMD at LS, FN, TH, and TBS were significantly lower in postmenopausal compared to premenopausal women.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Overall, 35% of postmenopausal women had osteoporosis by BMD or prior fragility fracture, and 4% had both. Three men\u2009\u2265\u200950\u00a0years had osteoporosis by BMD or fragility fracture (33.3%; <jats:italic>n<\/jats:italic>\u2009=\u20093\/9). This study suggests that close follow-up of skeletal health is necessary in postmenopausal women with chronic HypoPT and men\u2009\u2265\u200950\u00a0years.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00198-025-07410-7","type":"journal-article","created":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T13:47:31Z","timestamp":1739713651000},"page":"673-684","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Skeletal health status among patients with chronic hypoparathyroidism: results from the Canadian National Hypoparathyroidism Registry (CNHR)"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3733-8956","authenticated-orcid":false,"given":"Aliya A.","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajar","family":"AbuAlrob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalal S.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zayd","family":"Al Kassem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman","family":"Almoulia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habiba","family":"Afifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoela","family":"Braga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jouma","family":"Malhem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Millar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmett","family":"Morgante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parwana","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terri L.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ally","family":"Prebtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zubin","family":"Punthakee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayyab","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Shrayyef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stan","family":"Van Uum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Edward Massey","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Brandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Ovize","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blandine","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,16]]},"reference":[{"issue":"12","key":"7410_CR1","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1002\/jbmr.4716","volume":"37","author":"AA Khan","year":"2022","unstructured":"Khan AA, Guyatt G, Ali DS, Bilezikian JP, Collins MT, Dandurand K et al (2022) Management of hypoparathyroidism. J Bone Miner Res 37(12):2663\u20132677","journal-title":"J Bone Miner Res"},{"issue":"3","key":"7410_CR2","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1530\/EJE-18-0609","volume":"180","author":"AA Khan","year":"2019","unstructured":"Khan AA, Koch CA, Van Uum S, Baillargeon JP, Bollerslev J, Brandi ML et al (2019) Standards of care for hypoparathyroidism in adults: a Canadian and International Consensus. Eur J Endocrinol 180(3):P1-p22","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"7410_CR3","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1210\/jc.2015-3907","volume":"101","author":"ML Brandi","year":"2016","unstructured":"Brandi ML, Bilezikian JP, Shoback D, Bouillon R, Clarke BL, Thakker RV et al (2016) Management of hypoparathyroidism: summary statement and guidelines. J Clin Endocrinol Metab 101(6):2273\u20132283","journal-title":"J Clin Endocrinol Metab"},{"key":"7410_CR4","doi-asserted-by":"publisher","first-page":"17055","DOI":"10.1038\/nrdp.2017.55","volume":"3","author":"M Mannstadt","year":"2017","unstructured":"Mannstadt M, Bilezikian JP, Thakker RV, Hannan FM, Clarke BL, Rejnmark L et al (2017) Hypoparathyroidism. Nat Rev Dis Primers 3:17055","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"7410_CR5","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1002\/jbmr.4675","volume":"37","author":"S Bjornsdottir","year":"2022","unstructured":"Bjornsdottir S, Ing S, Mitchell DM, Sikjaer T, Underbjerg L, Hassan-Smith Z et al (2022) Epidemiology and financial burden of adult chronic hypoparathyroidism. J Bone Miner Res 37(12):2602\u20132614","journal-title":"J Bone Miner Res"},{"issue":"2","key":"7410_CR6","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s12020-021-02629-w","volume":"72","author":"AA Khan","year":"2021","unstructured":"Khan AA, AbuAlrob H, Punthakee Z, Shrayyef M, Werfalli RE, Kassem HA et al (2021) Canadian national hypoparathyroidism registry: an overview of hypoparathyroidism in Canada. Endocrine 72(2):553\u2013561","journal-title":"Endocrine"},{"issue":"5","key":"7410_CR7","doi-asserted-by":"publisher","first-page":"642","DOI":"10.20945\/2359-3997000000553","volume":"66","author":"BC Silva","year":"2022","unstructured":"Silva BC (2022) Skeletal and nonskeletal consequences of hypoparathyroidism. Arch Endocrinol Metab 66(5):642\u2013650","journal-title":"Arch Endocrinol Metab"},{"issue":"6","key":"7410_CR8","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1210\/clinem\/dgaa113","volume":"105","author":"JP Bilezikian","year":"2020","unstructured":"Bilezikian JP (2020) Hypoparathyroidism. J Clin Endocrinol Metab 105(6):1722\u20131736","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"7410_CR9","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1210\/jc.2015-3908","volume":"101","author":"BL Clarke","year":"2016","unstructured":"Clarke BL, Brown EM, Collins MT, J\u00fcppner H, Lakatos P, Levine MA et al (2016) Epidemiology and diagnosis of hypoparathyroidism. J Clin Endocrinol Metab 101(6):2284\u20132299","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"7410_CR10","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1002\/jbmr.4691","volume":"37","author":"AA Khan","year":"2022","unstructured":"Khan AA, Bilezikian JP, Brandi ML, Clarke BL, Gittoes NJ, Pasieka JL et al (2022) Evaluation and management of hypoparathyroidism summary statement and guidelines from the second international workshop. J Bone Miner Res 37(12):2568\u20132585","journal-title":"J Bone Miner Res"},{"issue":"2","key":"7410_CR11","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/cen.13895","volume":"90","author":"T Vadiveloo","year":"2019","unstructured":"Vadiveloo T, Donnan PT, Leese CJ, Abraham KJ, Leese GP (2019) Increased mortality and morbidity in patients with chronic hypoparathyroidism: a population-based study. Clin Endocrinol (Oxf) 90(2):285\u2013292","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"7410_CR12","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.ecl.2018.07.008","volume":"47","author":"MR Rubin","year":"2018","unstructured":"Rubin MR (2018) Skeletal manifestations of hypoparathyroidism. Endocrinol Metab Clin North Am 47(4):825\u2013837","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"7","key":"7410_CR13","first-page":"2135","volume":"80","author":"K Fujiyama","year":"1995","unstructured":"Fujiyama K, Kiriyama T, Ito M, Nakata K, Yamashita S, Yokoyama N et al (1995) Attenuation of postmenopausal high turnover bone loss in patients with hypoparathyroidism. J Clin Endocrinol Metab 80(7):2135\u20132138","journal-title":"J Clin Endocrinol Metab"},{"key":"7410_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6823-13-1","volume":"13","author":"ML Mendon\u00e7a","year":"2013","unstructured":"Mendon\u00e7a ML, Pereira FA, Nogueira-Barbosa MH, Monsignore LM, Teixeira SR, Watanabe PC et al (2013) Increased vertebral morphometric fracture in patients with postsurgical hypoparathyroidism despite normal bone mineral density. BMC Endocr Disord 13:1","journal-title":"BMC Endocr Disord"},{"issue":"11","key":"7410_CR15","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1002\/jbmr.3543","volume":"33","author":"MR Rubin","year":"2018","unstructured":"Rubin MR, Zhou H, Cusano NE, Majeed R, Omeragic B, Gomez M et al (2018) The effects of long-term administration of rhPTH(1\u201384) in hypoparathyroidism by bone histomorphometry. J Bone Miner Res 33(11):1931\u20131939","journal-title":"J Bone Miner Res"},{"issue":"12","key":"7410_CR16","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1359\/jbmr.080803","volume":"23","author":"MR Rubin","year":"2008","unstructured":"Rubin MR, Dempster DW, Zhou H, Shane E, Nickolas T, Sliney J Jr et al (2008) Dynamic and structural properties of the skeleton in hypoparathyroidism. J Bone Miner Res 23(12):2018\u20132024","journal-title":"J Bone Miner Res"},{"issue":"2","key":"7410_CR17","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s12020-016-1101-8","volume":"55","author":"C Cipriani","year":"2017","unstructured":"Cipriani C, Abraham A, Silva BC, Cusano NE, Rubin MR, McMahon DJ et al (2017) Skeletal changes after restoration of the euparathyroid state in patients with hypoparathyroidism and primary hyperparathyroidism. Endocrine 55(2):591\u2013598","journal-title":"Endocrine"},{"issue":"2","key":"7410_CR18","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00198-016-3750-0","volume":"28","author":"BC Silva","year":"2017","unstructured":"Silva BC, Rubin MR, Cusano NE, Bilezikian JP (2017) Bone imaging in hypoparathyroidism. Osteoporos Int 28(2):463\u2013471","journal-title":"Osteoporos Int"},{"issue":"6","key":"7410_CR19","first-page":"1617","volume":"76","author":"S Abugassa","year":"1993","unstructured":"Abugassa S, Nordenstr\u00f6m J, Eriksson S, Sj\u00f6d\u00e9n G (1993) Bone mineral density in patients with chronic hypoparathyroidism. J Clin Endocrinol Metab 76(6):1617\u20131621","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"7410_CR20","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.bone.2009.09.020","volume":"46","author":"MR Rubin","year":"2010","unstructured":"Rubin MR, Dempster DW, Kohler T, Stauber M, Zhou H, Shane E et al (2010) Three dimensional cancellous bone structure in hypoparathyroidism. Bone 46(1):190\u2013195","journal-title":"Bone"},{"issue":"12","key":"7410_CR21","doi-asserted-by":"publisher","first-page":"5795","DOI":"10.1210\/jc.2019-00698","volume":"104","author":"EN Sakane","year":"2019","unstructured":"Sakane EN, Vieira MCC, Lazaretti-Castro M, Maeda SS (2019) Predictors of poor bone microarchitecture assessed by trabecular bone score in postsurgical hypoparathyroidism. J Clin Endocrinol Metab 104(12):5795\u20135803","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"7410_CR22","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/8756-3282(95)00443-2","volume":"18","author":"BL Langdahl","year":"1996","unstructured":"Langdahl BL, Mortensen L, Vesterby A, Eriksen EF, Charles P (1996) Bone histomorphometry in hypoparathyroid patients treated with vitamin D. Bone 18(2):103\u2013108","journal-title":"Bone"},{"issue":"11","key":"7410_CR23","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1007\/s00198-021-05966-8","volume":"32","author":"R Pal","year":"2021","unstructured":"Pal R, Bhadada SK, Mukherjee S, Banerjee M, Kumar A (2021) Fracture risk in hypoparathyroidism: a systematic review and meta-analysis. Osteoporos Int 32(11):2145\u20132153","journal-title":"Osteoporos Int"},{"issue":"1","key":"7410_CR24","doi-asserted-by":"publisher","first-page":"e372","DOI":"10.1210\/clinem\/dgab577","volume":"107","author":"AA Khan","year":"2022","unstructured":"Khan AA, Rejnmark L, Rubin M, Schwarz P, Vokes T, Clarke B et al (2022) PaTH Forward: a randomized, double-blind, placebo-controlled phase 2 trial of TransCon PTH in adult hypoparathyroidism. J Clin Endocrinol Metab 107(1):e372\u2013e385","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"7410_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/jbmr.4726","volume":"38","author":"AA Khan","year":"2023","unstructured":"Khan AA, Rubin MR, Schwarz P, Vokes T, Shoback DM, Gagnon C et al (2023) Efficacy and safety of parathyroid hormone replacement with TransCon PTH in hypoparathyroidism: 26-week results from the phase 3 PaTHway trial. J Bone Miner Res 38(1):14\u201325","journal-title":"J Bone Miner Res"},{"key":"7410_CR26","doi-asserted-by":"crossref","unstructured":"Takacs I, Mezosi E, Soto A, Kamenick\u00fd P, Figueres L, Galvez Moreno MA et al (2024) An open-label phase 2 study of eneboparatide, a novel PTH receptor 1 agonist, in hypoparathyroidism. J Clin Endocrinol Metab 6:dgae121","DOI":"10.1210\/clinem\/dgae121"},{"issue":"5","key":"7410_CR27","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1177\/096721090201000501","volume":"10","author":"JY-H Tiao","year":"2002","unstructured":"Tiao JY-H, Semmens JB, Masarei JRL, Lawrence-Brown MMD (2002) The effect of age on serum creatinine levels in an aging population: relevance to vascular surgery. Cardiovasc Surg 10(5):445\u201351","journal-title":"Cardiovasc Surg"},{"issue":"8","key":"7410_CR28","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1080\/00365510410003057","volume":"64","author":"BE Vikse","year":"2004","unstructured":"Vikse BE, Vollset SE, Tell GS, Refsum H, Iversen BM (2004) Distribution and determinants of serum creatinine in the general population: the Hordaland Health Study. Scand J Clin Lab Invest 64(8):709\u2013722","journal-title":"Scand J Clin Lab Invest"},{"issue":"15","key":"7410_CR29","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1001\/archinte.159.15.1785","volume":"159","author":"BF Culleton","year":"1999","unstructured":"Culleton BF, Larson MG, Evans JC, Wilson PW, Barrett BJ, Parfrey PS et al (1999) Prevalence and correlates of elevated serum creatinine levels: the Framingham Heart Study. Arch Intern Med 159(15):1785\u20131790","journal-title":"Arch Intern Med"},{"issue":"5","key":"7410_CR30","doi-asserted-by":"publisher","first-page":"694","DOI":"10.20945\/2359-3997000000559","volume":"66","author":"T Palomo","year":"2022","unstructured":"Palomo T, Muszkat P, Weiler FG, Dreyer P, Brand\u00e3o CMA, Silva BC (2022) Update on trabecular bone score. Arch Endocrinol Metab 66(5):694\u2013706","journal-title":"Arch Endocrinol Metab"},{"issue":"3","key":"7410_CR31","doi-asserted-by":"publisher","first-page":"237","DOI":"10.4103\/ijem.IJEM_147_20","volume":"24","author":"R Rajan","year":"2020","unstructured":"Rajan R, Cherian KE, Kapoor N, Paul TV (2020) Trabecular bone score-an emerging tool in the management of osteoporosis. Indian J Endocrinol Metab 24(3):237\u2013243","journal-title":"Indian J Endocrinol Metab"},{"issue":"3","key":"7410_CR32","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.bone.2007.11.001","volume":"42","author":"JA Kanis","year":"2008","unstructured":"Kanis JA, McCloskey EV, Johansson H, Oden A, Melton LJ 3rd, Khaltaev N (2008) A reference standard for the description of osteoporosis. Bone 42(3):467\u2013475","journal-title":"Bone"},{"issue":"1","key":"7410_CR33","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12902-021-00888-2","volume":"21","author":"N Gittoes","year":"2021","unstructured":"Gittoes N, Rejnmark L, Ing SW, Brandi ML, Bj\u00f6rnsdottir S, Hahner S et al (2021) The PARADIGHM (physicians advancing disease knowledge in hypoparathyroidism) registry for patients with chronic hypoparathyroidism: study protocol and interim baseline patient characteristics. BMC Endocr Disord 21(1):232","journal-title":"BMC Endocr Disord"},{"issue":"7","key":"7410_CR34","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1530\/EC-20-0219","volume":"9","author":"S Gronskaia","year":"2020","unstructured":"Gronskaia S, Melnichenko G, Rozhinskaya L, Grebennikova T, Mamedova E, Pigarova E et al (2020) A registry for patients with chronic hypoparathyroidism in Russian adults. Endocr Connect 9(7):627\u2013636","journal-title":"Endocr Connect"},{"key":"7410_CR35","doi-asserted-by":"publisher","first-page":"800119","DOI":"10.3389\/fendo.2022.800119","volume":"13","author":"EV Kovaleva","year":"2022","unstructured":"Kovaleva EV, Eremkina AK, Elfimova AR, Krupinova JA, Bibik EE, Maganeva IS et al (2022) The Russian registry of chronic hypoparathyroidism. Front Endocrinol (Lausanne) 13:800119","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"7410_CR36","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00223-018-0411-7","volume":"103","author":"G Marcucci","year":"2018","unstructured":"Marcucci G, Cianferotti L, Parri S, Altieri P, Arvat E, Benvenga S et al (2018) HypoparaNet: a database of chronic hypoparathyroidism based on expert medical-surgical centers in Italy. Calcif Tissue Int 103(2):151\u2013163","journal-title":"Calcif Tissue Int"},{"issue":"11","key":"7410_CR37","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1007\/s12325-019-01102-5","volume":"36","author":"K Iqbal","year":"2019","unstructured":"Iqbal K, Dass N, Gip C, Vila J, Rylands AJ, Marelli C (2019) Defining the characteristics of chronic hypoparathyroidism not adequately controlled on conventional therapy: consensus findings of three European Delphi panels. Adv Ther 36(11):3007\u20133016","journal-title":"Adv Ther"},{"issue":"10","key":"7410_CR38","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s40618-018-0857-5","volume":"41","author":"A Meola","year":"2018","unstructured":"Meola A, Vignali E, Matrone A, Cetani F, Marcocci C (2018) Efficacy and safety of long-term management of patients with chronic post-surgical hypoparathyroidism. J Endocrinol Invest 41(10):1221\u20131226","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"7410_CR39","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1210\/jc.2015-3909","volume":"101","author":"DM Shoback","year":"2016","unstructured":"Shoback DM, Bilezikian JP, Costa AG, Dempster D, Dralle H, Khan AA et al (2016) Presentation of hypoparathyroidism: etiologies and clinical features. J Clin Endocrinol Metab 101(6):2300\u20132312","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"7410_CR40","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1002\/jbmr.1979","volume":"28","author":"L Underbjerg","year":"2013","unstructured":"Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L (2013) Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study. J Bone Miner Res 28(11):2277\u20132285","journal-title":"J Bone Miner Res"},{"issue":"3","key":"7410_CR41","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/jbmr.5650110307","volume":"11","author":"P Garnero","year":"1996","unstructured":"Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD (1996) Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 11(3):337\u2013349","journal-title":"J Bone Miner Res"},{"issue":"1","key":"7410_CR42","first-page":"251","volume":"102","author":"H Chawla","year":"2017","unstructured":"Chawla H, Saha S, Kandasamy D, Sharma R, Sreenivas V, Goswami R (2017) Vertebral fractures and bone mineral density in patients with idiopathic hypoparathyroidism on long-term follow-up. J Clin Endocrinol Metab 102(1):251\u2013258","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"7410_CR43","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1210\/clinem\/dgab076","volume":"106","author":"C Cipriani","year":"2021","unstructured":"Cipriani C, Minisola S, Bilezikian JP, Diacinti D, Colangelo L, Piazzolla V et al (2021) Vertebral fracture assessment in postmenopausal women with postsurgical hypoparathyroidism. J Clin Endocrinol Metab 106(5):1303\u20131311","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"7410_CR44","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s40618-023-02177-2","volume":"47","author":"I Slutzky-Shraga","year":"2024","unstructured":"Slutzky-Shraga I, Hirsch D, Gorshtein A, Masri-Iraqi H, Shochat T, Robenshtok E, Shimon I, Tsvetov G (2024) Features of patients and fracture risk in hypoparathyroidism; a single center study. J Endocrinol Invest 47(3):593\u2013601. https:\/\/doi.org\/10.1007\/s40618-023-02177-2","journal-title":"J Endocrinol Invest"},{"issue":"12","key":"7410_CR45","doi-asserted-by":"publisher","first-page":"5795","DOI":"10.1210\/jc.2019-00698","volume":"104","author":"EN Sakane","year":"2019","unstructured":"Sakane EN, Vieira MCC, Lazaretti-Castro M, Maeda SS (2019) Predictors of poor bone microarchitecture assessed by trabecular bone score in postsurgical hypoparathyroidism. J Clin Endocrinol Metab 104(12):5795\u20135803","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"7410_CR46","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1007\/s40618-022-01818-2","volume":"45","author":"S Saha","year":"2022","unstructured":"Saha S, Mannar V, Kandasamy D, Sreenivas V, Goswami R (2022) Vertebral fractures, trabecular bone score and their determinants in chronic hypoparathyroidism. J Endocrinol Invest 45(9):1777\u20131786","journal-title":"J Endocrinol Invest"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-025-07410-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-025-07410-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-025-07410-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T13:03:24Z","timestamp":1746795804000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-025-07410-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,16]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["7410"],"URL":"https:\/\/doi.org\/10.1007\/s00198-025-07410-7","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,16]]},"assertion":[{"value":"13 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethical approval for the present study was obtained from the Hamilton Integrated Research Ethics Board (Project No. 15196).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all participants per GCP guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Aliya A Khan: speaker and advisory board (Alexion, Amgen); speaker, advisory board, research funding (Ascendis); advisory board, research funding (Takeda); research funding (Amolyt, Calcilytix); Hajar Abu Alrob, Dalal S Ali, Abdulrahman Almoulia, Habiba Afifi, Manoela Braga, Alice Cheng, Jouma Malhem, Adam Millar, Emmett Morgante, Parwana Muhammad, Terri Paul, Ally Prebtani, Zubin Punthakee, Tayyab Khan, Sarah Khan, Fizsa Shah, Muhammad Shrayyef, Stan Van Uum, and James Edward Massey Young have no conflict of interest; Michel Ovize and Blandine Weiss are employees of Amolyt Pharma.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}